Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

Andrés J.M. Ferreri,Michele Reni,Stefania Dell’Oro,Fabio Ciceri,Massimo Bernardi,Lionello Camba,Maurilio Ponzoni,Maria Rosa Terreni,Maurizio Tomirotti,Michele Spina,E Villa

Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

2001

Andrés J.M. Ferreri
Michele Reni
Stefania Dell’Oro
Fabio Ciceri
Massimo Bernardi
Lionello Camba
Maurilio Ponzoni
Maria Rosa Terreni
Maurizio Tomirotti
Michele Spina
E Villa

Objectives: To assess the feasibility and the activity, as well as the efficacy to treat meninges, of chemotherapy (CHT) containing high-dose methotrexate (HD-MTX) followed by radia

Keywords:

Immunology
Pathology
Vincristine
Performance status
Primary central nervous system lymphoma
Methotrexate
Medicine
Radiation therapy
Procarbazine
Chemotherapy
Salvage therapy
Central nervous system disease
Lymphoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations